Eisai Co., Ltd. (4523.T) stock analysis

In our weekly check, Eisai Co., Ltd. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 15 pass, warnings: 6, red flags: 4.

About Eisai Co., Ltd.

Eisai Co., Ltd. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Japan, listed on JPX as 4523.T.

What our checks show for 4523.T

Red flags

Warning signs

Strengths

Next earnings report: 2026-11-10

Similar companies

TORNTPHARM.NS · LAURUSLABS.NS · LUPIN.NS · DIVISLAB.NS · 4507.T · SUNPHARMA.NS

Questions

What grade does Eisai Co., Ltd. (4523.T) have?

In our weekly check, Eisai Co., Ltd. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 15 pass, warnings: 6, red flags: 4. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 4523.T stock?

This week's biggest flags for Eisai Co., Ltd.: Thin margins, Dividend stretched, Deep past fall. In total 10 of 25 checks show a warning or a red flag.

What does Eisai Co., Ltd. do?

Eisai Co., Ltd. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Japan, listed on JPX as 4523.T.

When does Eisai Co., Ltd. report earnings next?

The next earnings report is expected on 2026-11-10. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis